PDL BioPharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 96   

Articles published

PDLI 7.03 -0.11 (-1.47%)
price chart
Why PDL BioPharma Inc. Stock Burst Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
PDL BioPharma (PDLI) Reports 4Q Earnings: It's a Miss  Wall Street Pit
PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2014 Results - Earnings ...  Seeking Alpha (registration)
PDL BioPharma is Oversold
In the case of PDL BioPharma Inc, the RSI reading has hit 23.8 - by comparison, the universe of dividend stocks covered by Dividend Channel currently has an average RSI of 51.3.
Related articles »  
Form 8-K PDL BIOPHARMA, INC. For: Mar 03
PDL Biopharma, Inc., et al., No. 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily dismissed without prejudice. Shortly thereafter, and in light of the dismissal of the Hampe case, two derivative lawsuits filed against the Company's directors, which ...
PDL BioPharma Named Top Dividend Stock With Insider Buying and 8.60% Yield  Nasdaq
PDL BioPharma, Inc. Price Target Update  Stafford Daily
PDL BioPharma, Inc. Short Interest Disclosure
PDL BioPharma, Inc. (NASDAQ:PDLI), A rise of 746,527 shares or 2.1% was seen in the short interest of PDL BioPharma, Inc.. Even as the interest increased from 36,356,890 shares on February 13,2015 to 37,103,417 shares on February 27,2015, the days ...
Biotech Stocks For Your Portfolio - MannKind (NASDAQ:MNKD), PDL ...  Wall Street Observer
First Week of November 20th Options Trading For PDL BioPharma (PDLI)
Investors in PDL BioPharma Inc (Symbol: PDLI) saw new options begin trading this week, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until ...
Closing Bell Reports: PDL BioPharma, Inc. (PDLI), Materials Select Sector ...  WallStreet Scope
Latest Developments: PDL BioPharma, Inc. (NASDAQ:PDLI), Ariad ...  Market News Call
How 7% Yielding PDL BioPharma Is Reinventing Itself
PDL BioPharma (NASDAQ:PDLI) is currently paying a dividend of 7% on a payout ratio of 36%. The stock is significantly undervalued as compared to the S&P 500 and to the biotech industry.
PDL BioPharmas Q3 Earnings and Revenues Increase Y/Y  Zacks.com
Related articles »  
Deadline in Lawsuit for Investors in PDL BioPharma Inc (PDLI) Shares ...
SAN DIEGO, Oct. 14, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of PDL BioPharma Inc (PDLI) over alleged Federal Securities Laws Violations by PDL ...
Related articles »  
PDL BioPharma Inc (PDLI) is Trading Lower on Unusual Volume for March 06
PDL BioPharma Inc ($PDLI) experienced unusually high volume on Mar. 06, as the stock lost 5.63% to a closing price of $6.70.
Ex-Dividend Reminder: PDL BioPharma, Hancock Holding and G&K Services
Looking at the universe of stocks we cover at Dividend Channel, on 3/3/15, PDL BioPharma Inc (NASD: PDLI), Hancock Holding Co.
Healthcare Sector Movers: Actavis plc (ACT), PDL BioPharma, Inc. (PDLI ...  WallStreet Scope
Relative Strength Alert For PDL BioPharma
But making PDL BioPharma Inc an even more interesting and timely stock to look at, is the fact that in trading on Tuesday, shares of PDLI entered into oversold territory, changing hands as low as $6.52 per share.